The molecular basis of antiphospholipid syndrome.
We herein review evidence that the phospholipid-binding protein beta2 glycoprotein-1 (beta2GPI) is a causative autoantigen in APS. Recent work suggests that the molecular regions in beta2GPI that facilitate autoimmunization are those that promote binding to negatively charged phospholipids by means of strong positive (anionic) charge and hydrophobicity. Although many common infections can cause antiphospholipid antibodies to be produced in humans, such postinfectious aPL are rarely associated with thromboses or pregnancy morbidity, the central features of antiphospholipid syndrome (APS). We propose that the causes of APS include those infectious agents that mimic the above molecular domains in beta2GPI. In people who are susceptible to APS, tolerance to self-beta2GPI and phospholipids is likely to be broken by foreign bacterial or viral proteins that contain such beta2GPI-like epitopes.
Gharavi
A E
AE
Department of Medicine, Morehouse School of Medicine, Atlanta, GA 30310-1495, USA. aghara@pol.net
Wilson
W
W
Pierangeli
S
S
D000818:Animals; D017152:Antibodies, Antiphospholipid / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D016736:Antiphospholipid Syndrome / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D003587:Cytomegalovirus / Q000276:immunology; D006023:Glycoproteins / Q000009:adverse effects / Q000276:immunology; D006801:Humans; D007114:Immunization; D009842:Oligopeptides / Q000276:immunology; D010743:Phospholipids / Q000009:adverse effects / Q000276:immunology
D017152:Antibodies, Antiphospholipid; D000956:Antigens, Viral; D006023:Glycoproteins; D009842:Oligopeptides; D010743:Phospholipids